{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:28:17Z","timestamp":1790785697919,"version":"4.1.0"},"reference-count":106,"publisher":"Informa UK Limited","issue":"4","funder":[{"DOI":"10.13039\/501100000951","name":"Cancer Council Victoria","doi-asserted-by":"publisher","award":["1139777"],"award-info":[{"award-number":["1139777"]}],"id":[{"id":"10.13039\/501100000951","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1084178"],"award-info":[{"award-number":["1084178"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Delivery"],"published-print":{"date-parts":[[2019,4,3]]},"DOI":"10.1080\/17425247.2019.1598374","type":"journal-article","created":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T23:26:30Z","timestamp":1553729190000},"page":"441-451","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":23,"title":["Epidermal growth factor receptor (EGFR)-targeted therapies in mesothelioma"],"prefix":"10.1080","volume":"16","author":[{"given":"Puey Ling","family":"Chia","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Austin Health, Melbourne, Australia"},{"name":"Tumour Targeting Laboratory, Olivia-Newton John Cancer Research Institute, Melbourne, Australia"},{"name":"Faculty of Medicine, University of Melbourne, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"Scott","sequence":"additional","affiliation":[{"name":"Tumour Targeting Laboratory, Olivia-Newton John Cancer Research Institute, Melbourne, Australia"},{"name":"Faculty of Medicine, University of Melbourne, Melbourne, Australia"},{"name":"School of Cancer Medicine, La Trobe University, Melbourne, Australia"},{"name":"Department of Molecular Imaging and Therapy, Austin Health, and University of Melbourne, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"John","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Austin Health, Melbourne, Australia"},{"name":"Faculty of Medicine, University of Melbourne, Melbourne, Australia"},{"name":"School of Cancer Medicine, La Trobe University, Melbourne, Australia"},{"name":"Cancer Immunobiology Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2019,4,18]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70149-8"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0000000000000064"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.11.136"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2016.11.1519"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-2665"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2011.01.001"},{"issue":"18","key":"cit0007","first-page":"5242","volume":"62","author":"Janne PA","year":"2002","journal-title":"Cancer Res"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(01)00231-3"},{"issue":"2","key":"cit0009","first-page":"333","volume":"152","author":"Pache JC","year":"1998","journal-title":"Am J Pathol"},{"issue":"4","key":"cit0010","doi-asserted-by":"crossref","first-page":"L684","DOI":"10.1152\/ajpcell.1999.277.4.C684","volume":"277","author":"Zanella CL","year":"1999","journal-title":"Am J Physiol"},{"issue":"105","key":"cit0011","first-page":"1073","author":"Jaurand MC","year":"1997","journal-title":"Environ Health Perspect"},{"issue":"2","key":"cit0012","first-page":"181","volume":"2","author":"Suzuki Y","year":"2009","journal-title":"Mol Med Rep"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1207163"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2005.10.016"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-008-0384-4"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.09.7634"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2010.11.004"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1002\/jso.21901"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2006.08.012"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1990.207"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1186\/s13000-014-0221-9"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1369\/jhc.2009.953554"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.11.069"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70318-7"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60569-9"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e318240ca0d"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1186\/1746-1596-1-19"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dji112"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2016.03.001"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2012-201194"},{"issue":"2","key":"cit0031","first-page":"126","volume":"4","author":"Khoo C","year":"2015","journal-title":"Transl Lung Cancer Res"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-8-142"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1038\/ng1975"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2011-200631"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1097\/PDM.0b013e3182a3645e"},{"key":"cit0036","volume-title":"AACR Annual Meeting","author":"Teruhisa TFT","year":"2008"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2013.130"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e31819c8661"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2015.3652"},{"key":"cit0040","first-page":"3","volume":"22","author":"Onder SGG","year":"2012","journal-title":"Int J Hematol Oncol"},{"issue":"6","key":"cit0041","first-page":"1523","volume":"151","author":"Petit AM","year":"1997","journal-title":"Am J Pathol"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-1940"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa050753"},{"key":"cit0044","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61758-4"},{"key":"cit0045","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(12)70087-6"},{"key":"cit0046","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.74.7576"},{"key":"cit0047","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa064320"},{"key":"cit0048","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx704"},{"issue":"17","key":"cit0049","first-page":"6500","volume":"61","author":"Albanell J","year":"2001","journal-title":"Cancer Res"},{"issue":"11","key":"cit0050","first-page":"1311","volume":"1","author":"Goldstein NI","year":"1995","journal-title":"Clin Cancer Res"},{"key":"cit0051","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa071834"},{"key":"cit0052","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.08.1620"},{"key":"cit0053","doi-asserted-by":"publisher","DOI":"10.4161\/mabs.1.1.7509"},{"issue":"7","key":"cit0054","first-page":"965","volume":"19","author":"Reardon DA","year":"2017","journal-title":"Neuro Oncol"},{"key":"cit0055","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2011.07.073"},{"key":"cit0056","doi-asserted-by":"publisher","DOI":"10.1593\/neo.04271"},{"key":"cit0057","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa040938"},{"key":"cit0058","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.00.992"},{"key":"cit0059","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-2618"},{"key":"cit0060","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6603665"},{"key":"cit0061","doi-asserted-by":"publisher","DOI":"10.1309\/AJCPST1CTHZS3PSZ"},{"key":"cit0062","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2017.04.028"},{"key":"cit0063","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-008-0206-6"},{"key":"cit0064","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7819-8-88"},{"key":"cit0065","unstructured":"Erlotinib hydrochloride in treating patients with malignant peritoneal mesothelioma (NCT01592383) 2017 [cited 2017 Aug 24]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01592383"},{"key":"cit0066","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23617"},{"key":"cit0067","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30621-6"},{"key":"cit0068","unstructured":"University Hospital G. Study of cetuximab combined with cisplatin or carboplatin\/pemetrexed as first line treatment in patients with malignant pleural mesothelioma (MesoMab NCT00996567). [cited 2018 Dec 21]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00996567"},{"key":"cit0069","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e318215a07d"},{"key":"cit0070","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-1726"},{"key":"cit0071","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2012.1607"},{"key":"cit0072","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/83.2.97"},{"key":"cit0073","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2001.04226.x"},{"key":"cit0074","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-2329"},{"key":"cit0075","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21184"},{"key":"cit0076","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-4518"},{"key":"cit0077","volume-title":"AACR Annual Meeting","author":"Sa\u00e9 Mu\u00f1iz-Hern\u00e1ndez VI-S","year":"2017"},{"key":"cit0078","unstructured":"Foundation ADR. mesomiR 1: a phase I study of targomiRs as 2nd or 3rd line treatment for patients with recurrent MPM and NSCLC (NCT02369198) 2017 [cited 2019 Feb 27]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02369198"},{"key":"cit0079","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdt412"},{"key":"cit0080","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-15-0583"},{"key":"cit0081","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.68.3672"},{"key":"cit0082","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.34.15_suppl.2509"},{"key":"cit0083","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.34.15_suppl.TPS8576"},{"key":"cit0084","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2017.09.328"},{"key":"cit0085","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-0804"},{"key":"cit0086","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-3898"},{"key":"cit0087","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0611693104"},{"key":"cit0088","doi-asserted-by":"publisher","DOI":"10.1021\/bc800289a"},{"key":"cit0089","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-15-0901"},{"key":"cit0090","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.34.15_suppl.2542"},{"key":"cit0091","doi-asserted-by":"crossref","unstructured":"Bent MJVD, French P, Eoli M, et al.\u00a0Updated results of the INTELLANCE 2\/EORTC trial 1410 randomized phase II study on Depatux \u2013M alone, Depatux-M in combination with temozolomide (TMZ) and either TMZ or lomustine (LOM) in recurrent EGFR amplified glioblastoma (NCT02343406) [Internet]. Chicago. J Clin Oncol. 2018;36(15_suppl):2023\u20132023. Available from: http:\/\/abstracts.asco.org\/214\/AbstView_214_211873.html","DOI":"10.1200\/JCO.2018.36.15_suppl.2023"},{"issue":"7","key":"cit0092","first-page":"1188","volume":"56","author":"Macsai-Kaplan ANM","year":"2015","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"cit0093","unstructured":"AbbVie. A Study Evaluating the Safety, Pharmacokinetics, and Anti-tumor Activity of ABBV-321 in Subjects With Advanced Solid Tumors Associated With Overexpression of the Epidermal Growth Factor Receptor (EGFR) or Its Ligands (NCT03234712). 2017."},{"key":"cit0094","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2018-743"},{"key":"cit0095","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3008226"},{"key":"cit0096","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-13-0170"},{"key":"cit0097","doi-asserted-by":"publisher","DOI":"10.2217\/imt-2016-0008"},{"key":"cit0098","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3010162"},{"key":"cit0099","unstructured":"Center MSKC. Malignant pleural disease treated with autologous T cells genetically engineered to target the cancer-cell surface antigen mesothelin 2018 [cited 2018 apr 23]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02414269"},{"key":"cit0100","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2017.10.001"},{"key":"cit0101","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-017-0238-6"},{"key":"cit0102","unstructured":"Hospital SCs. EGFR806 CAR T cell immunotherapy for recurrent\/refractory solid tumors in children and young adults (NCT03618381) 2018 [cited 2018 oct 8]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03618381"},{"key":"cit0103","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30169-9"},{"key":"cit0104","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.35.18_suppl.LBA8507"},{"key":"cit0105","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2017.1300656"},{"key":"cit0106","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2015.10.019"}],"container-title":["Expert Opinion on Drug Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17425247.2019.1598374","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T03:34:37Z","timestamp":1620444877000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17425247.2019.1598374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,3]]},"references-count":106,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4,3]]}},"alternative-id":["10.1080\/17425247.2019.1598374"],"URL":"https:\/\/doi.org\/10.1080\/17425247.2019.1598374","relation":{},"ISSN":["1742-5247","1744-7593"],"issn-type":[{"value":"1742-5247","type":"print"},{"value":"1744-7593","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iedd20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iedd20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2019-01-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-03-19","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-04-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}